click below
click below
Normal Size Small Size show me how
Drug Indications
| Question | Answer | Answer |
|---|---|---|
| Adrenaline | Cardiac arrest. Anaphylaxis. Severe asthma. Imminent respiratory arrest from COPD. Severe bradycardia. Blood pressure support if unresponsive to metaraminol. | Septic shock, cardiogenic shock and neurogenic shock unresponsive to 0.9% sodium chloride IV and metaraminol IV. Moderate to severe stridor. IN for clinically significant epistaxis. Topical for clinically significant bleeding from a wound. |
| Amoxicillin/clavulanic acid | Sepsis and: - The patient is aged greater than or equal to 12 years, and - One or more high risk factors are present, and - Time to hospital is greater than 30 minutes. | Cellulitis. In this setting a single IV dose may be administered if the patient is being referred to primary care and there may be a delay in the patient seeing a doctor |
| Asprin | Myocardial ischaemia. | |
| Ceftriaxone | Suspected meningococcal septicaemia. | |
| Droperidol | Patients aged greater than or equal to 12 years with agitated delirium causing a mild to moderate risk to safety, when olanzapine has not been administered or is ineffective | |
| Fentanyl | Moderate to severe pain. - Cardiogenic pulmonary oedema with severe anxiety. - Rapid sequence intubation. | Sedation post intubation. - Symptom control during end of life care. |
| Glucagon | Hypoglycaemia when the patient cannot safely swallow glucose/food and IV access cannot be obtained. | |
| Glucose Gel | Hypoglycaemia in adults and children provided the patient is conscious enough to be able to swallow safely. | Hypoglycaemia in neonates. |
| GTN Spray | Myocardial ischaemia. - Cardiogenic pulmonary oedema. - Control of hypertension associated with autonomic dysreflexia. | - Control of hypertension (usually in conjunction with labetalol or metoprolol) prior to fibrinolytic treatment for STEMI. - Control of hypertension (usually in conjunction with labetalol or metoprolol) during inter-hospital transfer for STEMI. |
| Ibuprofen | Mild pain (usually in combination with paracetamol), particularly soft tissue pain, musculoskeletal pain or headache. | May be administered in addition to other medicines for moderate to severe pain, particularly when the transport time is long. This is not a priority but will reduce the need for subsequent analgesia and improve the quality of pain relief. |
| Ipratropium | Bronchospasm secondary to asthma or COPD. | Prominent bronchospasm secondary to airway burns, smoke inhalation or chest infection. |
| Ketamine | Severe pain - Inducing dissociation, - Agitated delirium causing a severe to immediately life-threatening risk to safety. - RSI | Significant movement during CPR that is interfering with resuscitation. - Asthma with severe agitation that is impairing the ability to safely provide treatment and/or transport. |
| %1 Lignocaine | Subcutaneous injection for prophylaxis of pain associated with IV cannulation. Subcutaneous injection for digital ring blocks for analgesia. | Intraosseous injection for bone pain associated with fluid infusion via an intraosseous needle |
| Loratadine | Minor allergic reactions confined to skin involvement. | Prominent itch associated with anaphylaxis, provided all systemic signs of anaphylaxis have resolved. |
| Methoxyflurane | Moderate to severe pain when: - Personnel able to administer fentanyl and/or ketamine are not available within an appropriate time, or | Fentanyl and/or ketamine administration is inappropriate. |
| Midazolam | Prolonged seizures. - Agitated delirium causing a mild to moderate risk to safety and droperidol is unavailable or ineffective. - Pain associated with severe muscle spasm. | Sedation, for example for joint relocation. - Sedation post intubation. - Severe anxiety associated with COPD. |
| Naloxone | Opiate poisoning is suspected and the patient has a significantly impaired level of consciousness or significantly impaired breathing. | Excess adverse effects from administration of opiates. |
| Ondansetron | Clinically significant nausea and/or vomiting. | |
| Oxytocin | Following normal birth. | Postpartum haemorrhage. |
| Paracetamol | Mild or moderate pain, usually in combination with other medicines. | Paracetamol may be administered in addition to other medicines for severe pain, particularly if the transport time is long. This is not a priority but will reduce the need for subsequent analgesia and improve the quality of pain relief. |
| Prednisone and Prednisolone | Bronchospasm associated with asthma or COPD. - Croup. | Prominent rash associated with anaphylaxis, provided all systemic signs of anaphylaxis have resolved. - Minor allergy associated with rash. |
| Salbutamol | Bronchospasm secondary to asthma or COPD. | Prominent bronchospasm secondary to airway burns, smoke inhalation or chest infection. - Release syndrome following crush injury. |
| Tramadol | Aged greater than or equal to 12 years with moderate to severe pain (usually in combination with paracetamol and/or ibuprofen), particularly if personnel are not available to administer fentanyl and/or ketamine. | |
| TXA | Postpartum haemorrhage. - Hypovolaemia from uncontrolled bleeding. | Any other form of bleeding severe enough to cause hypovolaemia requiring 0.9% sodium chloride to be administered IV. |